CLDN19
protein-codingclaudin 19, the group of Claudins
Gene summary
The product of this gene belongs to the claudin family. It plays a major role in tight junction-specific obliteration of the intercellular space, through calcium-independent cell-adhesion activity. Defects in this gene are the cause of hypomagnesemia renal with ocular involvement (HOMGO). HOMGO is a progressive renal disease characterized by primary renal magnesium wasting with hypomagnesemia, hypercalciuria and nephrocalcinosis associated with severe ocular abnormalities such as bilateral chorioretinal scars, macular colobomata, significant myopia and nystagmus. Alternatively spliced transcript variants encoding distinct isoforms have been identified for this gene. [provided by RefSeq, Jun 2010]
MANE transcript
Inheritance
ClinVar variants
Top phenotype
gnomAD constraint
Max pathogenic AF
Genomic locus
External References & Databases
Transcript & Mutation Effects
hg38 • Region Span ~7.2 kbGenCC Phenotypes & Disease Associations
Curated gene-disease validity assertions and inheritance patterns
Inheritance Pattern: AR
Disease ID:MONDO:0009548
Submitter: G2P
Inheritance Pattern: AR
Disease ID:MONDO:0009548
Submitter: Labcorp Genetics (formerly Invitae)
Inheritance Pattern: AR
Disease ID:MONDO:0009548
Submitter: Ambry Genetics
Inheritance Pattern: AR
Disease ID:MONDO:0009548
Submitter: Orphanet
Clinical Genomic Database (CGD)
Manifestation: Ophthalmologic; Renal
Intervention: Renal
Rationale: Electrolyte replacement and surveillance for sequelae such as urinary tract infections can be beneficial
ClinVar Associated Diseases & Phenotypes
Reported disease conditions connected to CLDN19 variants in ClinVar
ClinVar Variants & Pathogenicity by Type
Statistics based on transcript NM_148960.3. Only rare variants are included.
We include only reliable ClinVar variants with their consequences to MANE Select, MANE Plus Clinical transcripts, or transcripts with TSL equal to 1. Click a count to filter the variants table below.
Slight differences between displayed counts and ClinVar may occur due to a different transcript/consequence chosen by our variant effect predictor, or because we classify Benign/Likely benign as Likely benign and Pathogenic/Likely pathogenic as Likely pathogenic.
| Effect | PathogenicP | Likely pathogenicLP | VUS | Likely benignLB | BenignB | Sum |
|---|---|---|---|---|---|---|
| synonymous | 30 | 30 | ||||
| missense | 3 | 12 | 64 | 4 | 1 | 84 |
| nonsense | 3 | 2 | 1 | 6 | ||
| start loss | 0 | |||||
| frameshift | 1 | 4 | 1 | 6 | ||
| splice donor/acceptor (+/-2bp) | 2 | 2 | 1 | 5 | ||
| Total | 9 | 20 | 67 | 34 | 1 | 131 |
Highest pathogenic variant AF is 0.000023451801
Transcript Catalog
Annotated transcript isoforms across RefSeq and Ensembl databases
| Transcript ID | Source | Protein ID | Coding Exons | MANE Status |
|---|---|---|---|---|
| RefSeq | NP_683763.2 | 5 | MANE Select | |
| Ensembl | ENSP00000296387.1 | 5 | MANE Select | |
| RefSeq | NP_001116867.1 | 4 | Standard | |
| RefSeq | NP_001172046.1 | 3 | Standard |
Gene Ontology (GO) Annotations & Pathways
Biological processes, molecular functions, cellular components and pathways
Pathways ConsensusPathDB
- Cell adhesion molecules (CAMs) - Homo sapiens (human)
- Tight junction - Homo sapiens (human)
- Hepatitis C - Homo sapiens (human)
- Leukocyte transendothelial migration - Homo sapiens (human)
- EMT transition in Colorectal Cancer
Biological Process
- visual perception
- calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules
- neuronal action potential propagation
- apical junction assembly
- response to stimulus
Molecular Function
- structural molecule activity
- identical protein binding
Cellular Component
- nucleus
- cytoplasm
- bicellular tight junction
- integral component of membrane
- basolateral plasma membrane
gnomAD Constraint
Source:
- Gene type
- protein_coding
- Transcript type
- protein_coding
- Transcript
- ENST00000296387
- Coding exons
- 5
- Length
- 7162
- Individuals with no LoFs
- 125695
- Homozygous LoFs
- 0
- Heterozygous LoFs
- 5
- Defined
- 125700
- p
- 0.0000199
| Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible | |
|---|---|---|---|---|---|---|
| Missense | 0.779 | 112 | 138 | 0.813 | 0.00000866 | 1389 |
| Missense (PolyPhen) | 44 | 58.186 | 0.75619 | 590 | ||
| Synonymous | 1.46 | 49 | 63.8 | 0.768 | 0.00000461 | 497 |
| Loss of Function | 1.40 | 5 | 9.71 | 0.515 | 4.17e-7 | 108 |
Population LoF Frequency
| Population | CAF | p-value | Status |
|---|---|---|---|
| African | 0 | 0.0 | absent |
| Latino/Admixed American | 0 | 0.0 | absent |
| Ashkenazi Jewish | 0 | 0.0 | absent |
| East Asian | 0 | 0.0 | absent |
| Finnish | 0.000095 | 0.000092 | rare |
| European (Non-Finnish) | 0.000018 | 0.000018 | rare |
| South Asian | 0.000033 | 0.000033 | rare |
| Other | 0 | 0.0 | absent |
dbNSFP Gene Annotations
Source:
- Function
- FUNCTION: Plays a major role in tight junction-specific obliteration of the intercellular space, through calcium- independent cell-adhesion activity. {ECO:0000250|UniProtKB:Q9ET38}.;
- Disease
- DISEASE: Hypomagnesemia 5, renal, with or without ocular involvement (HOMG5) [MIM:248190]: A progressive renal disease characterized by primary renal magnesium wasting with hypomagnesemia, hypercalciuria and nephrocalcinosis associated with severe ocular abnormalities such as bilateral chorioretinal scars, macular colobomata, significant myopia and nystagmus. The renal phenotype is virtually undistinguishable from that of patients with HOMG3. {ECO:0000269|PubMed:17033971}. Note=The disease is caused by mutations affecting the gene represented in this entry.;
Recessive Scores
- pRec
- 0.142
Intolerance Scores
- LoFtool
- 0.0854
- RVIS EVS
- 0.68
- RVIS percentile EVS
- 84.93
Essentials
- Essential (CRISPR)
- N
- Essential (CRISPR2)
- N
- Essential (gene trap)
- N
- Indispensability pred.
- N
- Indispensability score
- 0.269
Gene Damage Prediction
| All | Recessive | Dominant | |
|---|---|---|---|
| Mendelian | Medium | Medium | Medium |
| Primary Immunodeficiency | Medium | Medium | Medium |
| Cancer | Medium | Medium | Medium |